(2020). Correction: Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study. J Immunother Cancer.
Chicago Style Citation"Correction: Development and Validation of a Genomic Mutation Signature to Predict Response to PD-1 Inhibitors in Non-squamous NSCLC: A Multicohort Study." J Immunother Cancer 2020.
Cita MLA"Correction: Development and Validation of a Genomic Mutation Signature to Predict Response to PD-1 Inhibitors in Non-squamous NSCLC: A Multicohort Study." J Immunother Cancer 2020.
Atenció: Aquestes cites poden no estar 100% correctes.